Research Article
The Incidence and Risk Factors of Hip Fracture after Liver Transplantation (LT): A Nationwide Population-Based Study
Table 1
Demographic profiles for the control and recipient cohorts.
| | Variable | Control cohort | Recipient cohort | value | | N = 22010 | N = 2201 |
| | Age (year) | 51.6 ± 9.8 | 51.7 ± 9.7 | 0.9371 | | Sex | | | >0.99 | | Female | 5620 (25.5%) | 562 (25.5%) | | | Male | 16390 (74.5%) | 1639 (74.5%) | | | Comorbidities | | CAD | 3189 (14.5%) | 292 (13.3%) | 0.1192 | | DM | 2508 (11.4%) | 546 (24.8%) | <0.0001 | | Epilepsy | 197 (0.9%) | 29 (1.3%) | 0.0494 | | Hypertension | 6613 (30.0%) | 721 (32.8%) | 0.0083 | | Osteoporosis | 1107 (5.0%) | 140 (6.4%) | 0.0071 | | Stroke | 543 (2.5%) | 70 (3.2%) | 0.0422 | | ESRD | 103 (0.5%) | 28 (1.3%) | <0.0001 | | HBV infection | 990 (4.5%) | 1477 (67.1%) | <0.0001 | | HCV infection | 350 (1.6%) | 630 (28.6%) | <0.0001 | | Steroid | 11858 (53.9%) | 2061 (93.6) | |
|
|
CAD: coronary artery disease; DM: diabetes mellitus; ESRD: end-stage renal disease; HBV: hepatitis B virus; HCV: hepatitis C virus infection.
|
